Skip to content

13F-HR filed by Nekton Capital Ltd.

Nekton Capital Ltd. filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 17 holding rows worth $367,108,000.

Accession
0001884716-22-000006
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 17 entries on the cover page, a total value of $367,108,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $367,108,000 with VALUE read as thousands by filing date, 13F file number 028-21718. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QIAGEN NVN72482123SHS NEW1,770,431$73,083,000thousands by filing date
GENERAL MTRS CO COM37045V100Stock1,085,200$45,578,000thousands by filing datecall
Alphabet Inc. Reg. Shares A02079K305COM385,385$36,862,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock286,028$29,904,000thousands by filing date
ELECTRONIC ARTS INC COM285512109Stock247,916$28,686,000thousands by filing date
JACOBS SOLUTIONS INC COM46982L108Stock197,867$21,467,000thousands by filing date
SHAW COMMUNICATIONS INC82028K200CL B CONV749,749$18,211,000thousands by filing date
EXPEDIA GROUP INC COM NEW30212P303Stock175,038$16,399,000thousands by filing date
GODADDY INC CL A380237107Stock189,850$13,457,000thousands by filing date
Medtronic PlcG5960L103COM163,275$13,184,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM152,632$12,939,000thousands by filing date
TAKE-TWO INTERACTIVE SOFTWARE COM874054109Stock110,888$12,087,000thousands by filing date
GENERAL MTRS CO COM37045V100Stock360,000$11,552,000thousands by filing date
BROOKFIELD ASSET MANAGEMENT IN112585104CL A LTD VT SH235,375$9,624,000thousands by filing date
CNH INDL N V SHSN20944109Stock854,929$9,550,000thousands by filing date
LITHIUM AMERS CORP NEW53680Q207COM NEW295,146$7,742,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock33,890$6,783,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001884716-22-000006this filing2022-11-14acceptance time not in the bulk data set